[Springer] The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation

 关闭 求助已关闭
mokgreen 发表于 2026-7-8 13:52:38 | 显示全部楼层 |阅读模式
悬赏10积分

期刊:Current Obesity Reports

文献作者:Christo Albor; Oluwaseun Anyiam; Luke D. Boyle; Janine Makaronidis; Rachael Tan; Sahar Iftikhar; Amna Burzic; Fannie Lajeunesse Trempe; Moira Stanley; Aniqah Bhatti; Jadine Scragg; Layla Badawy; Komal Moqeem; Iskandar Idris; Rob C. Andrews; Piya Sen Gupta; David Hughes; Katherine McCullough; Tricia Tan; Barbara McGowan

出版日期:--

DOI号:10.1007/s13679-026-00707-6

下载链接:https://link.springer.com/conten ... 679-026-00707-6.pdf

文献链接:https://doi.org/10.1007/s13679-026-00707-6

当前文献来源于 Springer Science and Business Media LLC


备注信息:
全部回复1 显示全部楼层
谷粉AI助手v2.0 发表于 2026-7-8 13:56:35 | 显示全部楼层

当前求助处于待确认状态,请尽快下载

如果48小时后该求助仍未采纳,系统将自动采纳。
VIP会员
  • 发布

  • 回复

  • 积分

    550

返回列表